Microsoft Word - S_2019_GRC-02_025_S43 Share Acquisition_EN Page 1 – Translation – GRC-02/2019/025 11 December 2019 Subject: Report of the Asset Acquisition To: President The Stock Exchange of

commission were THB 128.68 million, an increase of THB 9.04 million or 7.55 per cent. The result from cost’s increasing related revenue’s increasing. As the Company has a policy to control costs substantially

year amount of THB 9.01 million or 7.87 per cent. As the Company has a policy to control costs substantially. (2) The administrative expenses of the Consolidated Financial Statement amount of THB 49.87

increased substantially which can outweigh lower visit number. The increase of revenue per visit was the result of more surgeries operated particularly heart surgeries and minimal invasive surgeries. All

significant increase in gross profit margin, which substantially pushed up its net profit and net profit margin. บริษัท ดโีอด ีไบโอเทค จ ำกดั (มหำชน) 111 หมู่ที่ 2 ต ำบลท่ำจีน อ ำเภอเมืองสมุทรสำคร จังหวดัสมุทร

, which substantially pushed up its net profit and net profit margin. Financial position The Company recorded total assets of Baht 1,415.19 million as at September 30, 2018, a Baht 960.99 million or 211.57

) increased substantially by 25% yoy. EBITDA margin rose from 23% of hospital revenue in 2Q’18 to 26% in 2Q’19. The promising EBITDA was attributable to not only the revenue growth but also the effective cost

substantially pushed up its net profit and net profit margin. Financial position The Company recorded total assets of Baht 1,424.80 million as at June 30, 2018, a Baht 970.60 million or 213.69% growth from that

the major of shareholders, directors, and executive of the Company at the price of THB 35 per share, totaling THB 435,3 5 4 ,080 ( the detail of the acquisition of shares of Rajthanee-Rojana Hospital

. However, the loss decreased substantially. Please be informed accordingly. Yours sincerely, Chanet Phenjati President